跳至主要内容
临床试验/IRCT20121110011424N5
IRCT20121110011424N5已完成3 期

Effects of Memantine on cognitive profile of patients with epilepsy: A randomized, double-blind, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 65 years(—)
性别
All

入选标准

  • Patients between 15-65 years old
  • Epileptic patients who received anti epileptic drugs over 6 months with mild to moderate cognition impairment
  • Seizure episodes less than four times a month

排除标准

  • Progressive neurologic disease, psychiatric disorders, and mental retardation
  • Severe medical illnesses such as renal failure
  • Pregnancy or breast feeding
  • Patients during inter-ictal phase (2 weeks)
  • Patients with seizure episodes more than four times a month
  • adverse drug effect
  • drug allergy or intolerance

研究者

相似试验